National Perinatal Association
No matter how you are involved across the spectrum of care for mothers, babies and families, the NPA provides programs, services and opportunities to learn and engage. At NPA, we focus on the impact and effect of perinatal care and policy on families and the healthcare providers who care for them – ensuring their voices are heard.
Learn more about how you can become a member and access what NPA has to offer.
Save the Date for NPA's 38th Annual Conference
Perinatal Mental Health: Advocating for the Health and Wellbeing of Families
March 9-11, 2017 | Atlanta, Georgia
For sponsorship opportunities, contact Kristy Love at firstname.lastname@example.org
Our venue will be the Embassy Suites by Hilton Atlanta at Centennial Olympic Park
We are proud to announce NPA's
Interdisciplinary Recommendations for Psychosocial Support of NICU Parents
In January 2014, the National Perinatal Association convened a group of thought leaders and stakeholders - neonatologists, obstetricians, nurses, nurse practitioners, nurse midwives, developmental care specialists, psychologists, social workers, public health experts, parent support group leaders and parents - to develop interdisciplinary guidelines for psychosocial support services for parents whose infants are hospitalized in neonatal intensive care units (NICUs).
This group convened with the common purpose of improving the level of psychosocial support provided to NICU parents as well as improving training and support for those who provide care in NICUs.The products of this interdisciplinary endeavor are:
You can download the Interdisciplinary Recommendations for Psychosocial Support of NICU Parents here, without the supporting narrative and references.
Click here to view the full set of articles with references in the Supplement to the December, 2015 issue of Journal of Perinatology.
NPA's Family Advocacy Network (FAN) now hosts quarterly webinars in partnership with the Preemie Parent Alliance (PPA) Find out more.
NPA's Egg Freezing position paper is now available.
The Development of New Pharmacological Therapies for Infants - The National Perinatal Association’s Position of Support for Senate Bill S.2041 by by Sue Hall, MD; Raylene Phillips, MD; Vincent C. Smith, MD; Cris Glick, MD; Mitchell Goldstein, MD; T. Allen Merritt, MD
“Despite a recognition by Congress that children’s interests are not being met with pediatric pharmaceutical development, very little progress has been made to meet this need. As a result, efforts to offer even more incentives to pharmaceutical companies such as those described in Bill S.2041 are being made.”